2-[3-methoxy-4-[[4-[6-(1,2-oxazol-3-yl)-2-pyridinyl]pyrimidin-2-yl]amino]pyrazol-1-yl]propane-1,3-diol
C19H19N7O4 — CID 170382577
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-methoxy-4-[[4-[6-(1,2-oxazol-3-yl)-2-pyridinyl]pyrimidin-2-yl]amino]pyrazol-1-yl]propane-1,3-diol
2-[3-methoxy-4-[[4-[6-(1,2-oxazol-3-yl)-2-pyridinyl]pyrimidin-2-yl]amino]pyrazol-1-yl]propane-1,3-diol (PubChem CID 170382577) has the molecular formula C19H19N7O4 and a molecular weight of 409.41 g/mol. Its IUPAC name is 2-[3-methoxy-4-[[4-[6-(1,2-oxazol-3-yl)-2-pyridinyl]pyrimidin-2-yl]amino]pyrazol-1-yl]propane-1,3-diol.
Molecular Properties
| Compound Name | 2-[3-methoxy-4-[[4-[6-(1,2-oxazol-3-yl)-2-pyridinyl]pyrimidin-2-yl]amino]pyrazol-1-yl]propane-1,3-diol |
|---|---|
| PubChem CID | 170382577 |
| Molecular Formula | C19H19N7O4 |
| Molecular Weight | 409.41 g/mol |
| Exact Mass | 409.15 |
| IUPAC Name | 2-[3-methoxy-4-[[4-[6-(1,2-oxazol-3-yl)-2-pyridinyl]pyrimidin-2-yl]amino]pyrazol-1-yl]propane-1,3-diol |
| SMILES | COc1nn(C(CO)CO)cc1Nc1nccc(-c2cccc(-c3ccon3)n2)n1 |
| InChI | InChI=1S/C19H19N7O4/c1-29-18-17(9-26(24-18)12(10-27)11-28)23-19-20-7-5-15(22-19)13-3-2-4-14(21-13)16-6-8-30-25-16/h2-9,12,27-28H,10-11H2,1H3,(H,20,22,23) |
| InChIKey | DZULBPLSNFRENC-UHFFFAOYSA-N |
| XLogP | 1.67 |
| TPSA | 144.24 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.41 |
| LogP ≤ 5 | 1.67 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170382577 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.